REPORT ID 15329

United States Intravenous Immunoglobulin (IVIg) Market Report 2017

Publish Date
29-Nov-17
Pages
105
Format
Electronic (PDF)

In this report, the United States Intravenous Immunoglobulin (IVIg) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Intravenous Immunoglobulin (IVIg) in these regions, from 2012 to 2022 (forecast).

United States Intravenous Immunoglobulin (IVIg) market competition by top manufacturers/players, with Intravenous Immunoglobulin (IVIg) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    CSL Behring
    Grifols
    Octapharma
    Shire
    ADMA Biologics
    Bayer
    Bharat Serum and Vaccines
    Biotest
    China Biologic Products
    Hualan Biological Engineering
    Kedrion Biopharma
    Sanquin

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Neurology
    Hematology
    Immunology
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Immunology
    Oncology
    Pulmonology
    Rheumatology
    Transplant
    Neurology
    Hematology
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Intravenous Immunoglobulin (IVIg) Market Report 2017
1 Intravenous Immunoglobulin (IVIg) Overview
    1.1 Product Overview and Scope of Intravenous Immunoglobulin (IVIg)
    1.2 Classification of Intravenous Immunoglobulin (IVIg) by Product Category
        1.2.1 United States Intravenous Immunoglobulin (IVIg) Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Intravenous Immunoglobulin (IVIg) Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Neurology
        1.2.4 Hematology
        1.2.5 Immunology
    1.3 United States Intravenous Immunoglobulin (IVIg) Market by Application/End Users
        1.3.1 United States Intravenous Immunoglobulin (IVIg) Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Immunology
        1.3.3 Oncology
        1.3.4 Pulmonology
        1.3.5 Rheumatology
        1.3.6 Transplant
        1.3.7 Neurology
        1.3.8 Hematology
        1.3.9 Others
    1.4 United States Intravenous Immunoglobulin (IVIg) Market by Region
        1.4.1 United States Intravenous Immunoglobulin (IVIg) Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Intravenous Immunoglobulin (IVIg) Status and Prospect (2012-2022)
        1.4.3 Southwest Intravenous Immunoglobulin (IVIg) Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Intravenous Immunoglobulin (IVIg) Status and Prospect (2012-2022)
        1.4.5 New England Intravenous Immunoglobulin (IVIg) Status and Prospect (2012-2022)
        1.4.6 The South Intravenous Immunoglobulin (IVIg) Status and Prospect (2012-2022)
        1.4.7 The Midwest Intravenous Immunoglobulin (IVIg) Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Intravenous Immunoglobulin (IVIg) (2012-2022)
        1.5.1 United States Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2012-2022)
        1.5.2 United States Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate (2012-2022)

2 United States Intravenous Immunoglobulin (IVIg) Market Competition by Players/Suppliers
    2.1 United States Intravenous Immunoglobulin (IVIg) Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Intravenous Immunoglobulin (IVIg) Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Intravenous Immunoglobulin (IVIg) Average Price by Players/Suppliers (2012-2017)
    2.4 United States Intravenous Immunoglobulin (IVIg) Market Competitive Situation and Trends
        2.4.1 United States Intravenous Immunoglobulin (IVIg) Market Concentration Rate
        2.4.2 United States Intravenous Immunoglobulin (IVIg) Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Intravenous Immunoglobulin (IVIg) Manufacturing Base Distribution, Sales Area, Product Type

3 United States Intravenous Immunoglobulin (IVIg) Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Intravenous Immunoglobulin (IVIg) Sales and Market Share by Region (2012-2017)
    3.2 United States Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Region (2012-2017)
    3.3 United States Intravenous Immunoglobulin (IVIg) Price by Region (2012-2017)

4 United States Intravenous Immunoglobulin (IVIg) Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Intravenous Immunoglobulin (IVIg) Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Type (2012-2017)
    4.3 United States Intravenous Immunoglobulin (IVIg) Price by Type (2012-2017)
    4.4 United States Intravenous Immunoglobulin (IVIg) Sales Growth Rate by Type (2012-2017)

5 United States Intravenous Immunoglobulin (IVIg) Sales (Volume) by Application (2012-2017)
    5.1 United States Intravenous Immunoglobulin (IVIg) Sales and Market Share by Application (2012-2017)
    5.2 United States Intravenous Immunoglobulin (IVIg) Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Intravenous Immunoglobulin (IVIg) Players/Suppliers Profiles and Sales Data
    6.1 CSL Behring
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 CSL Behring Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Grifols
        6.2.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Octapharma
        6.3.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Shire
        6.4.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Shire Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 ADMA Biologics
        6.5.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 ADMA Biologics Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Bayer
        6.6.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Bayer Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Bharat Serum and Vaccines
        6.7.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Bharat Serum and Vaccines Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Biotest
        6.8.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 China Biologic Products
        6.9.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 China Biologic Products Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Hualan Biological Engineering
        6.10.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Hualan Biological Engineering Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Kedrion Biopharma
    6.12 Sanquin

7 Intravenous Immunoglobulin (IVIg) Manufacturing Cost Analysis
    7.1 Intravenous Immunoglobulin (IVIg) Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Intravenous Immunoglobulin (IVIg) Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Intravenous Immunoglobulin (IVIg) Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Intravenous Immunoglobulin (IVIg) Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Intravenous Immunoglobulin (IVIg) Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Intravenous Immunoglobulin (IVIg) Sales Volume Forecast by Type (2017-2022)
    11.3 United States Intravenous Immunoglobulin (IVIg) Sales Volume Forecast by Application (2017-2022)
    11.4 United States Intravenous Immunoglobulin (IVIg) Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer